Acurx Pharmaceuticals announced the completion of a direct offering, raising $2.5 million through the sale of 825,085 common shares. The shares were priced at $3.03 each, providing capital for the company's operations.
Acurx Pharmaceuticals Completes $2.5 Million Direct Stock Offering
PharmaceuticalsDirect OfferingEquity FinancingBiotechCapital Raise
